Anbio Biotechnology: retained_earnings
| Value | {"amount": 14800699, "concept": "us-gaap:RetainedEarningsAccumulatedDeficit", "currency": "USD"} |
|---|---|
| Period | (as of 2023-12-31) |
| Status | current |
| Entity | Anbio Biotechnology |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c302d5f0-2081-451d-aaaa-483694b11f35
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-035802Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001982708/retained-earnings/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c302d5f0-2081-451d-aaaa-483694b11f35
History
- no predecessors — first report